Evidence map›Paper›PMID 36918908›Full record

SynthesisSystematic reviews2023

Keloid treatments: an evidence-based systematic review of recent advances.

Laura A Walsh, Ellen Wu, David Pontes, Kevin R Kwan, Sneha Poondru, Corinne H Miller, Roopal V Kundu

Registry-linked trialOpen access · goldFull text readSystematic Review
In one paragraph

Synthesis in Systematic reviews, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06230146 (Efficacy and Safety of Fractional CO2 Laser Combined With Intralesional Insulin, Botulinum Toxin or Triamcinolone Acetonide in the Treatment of Keloid), which is not on this map. Cited by 80 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed, 5 pooled it
36.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06230146 phase1 / phase2unknown statusnot on this mapstarted 2024, after this paper: background citation

Efficacy and Safety of Fractional CO2 Laser Combined With Intralesional Insulin, Botulinum Toxin or Triamcinolone Acetonide in the Treatment of Keloid: A Clinical, Dermoscopic and Immunohistochemical Study.

TypeinterventionalSponsorAssiut UniversityRan2024 to 2026Enrolled45ConditionsKeloidArmsInsulin group, Botulinum toxin group, Triamcinolone acetonide group
3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 5 syntheses or guidelines pooled it, 127 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Laura A WalshNorthwestern University Feinberg School of Medicine, Chicago, IL, USA.
Ellen WuNorthwestern University Feinberg School of Medicine, Chicago, IL, USA.
David PontesNorthwestern University Feinberg School of Medicine, Chicago, IL, USA.
Kevin R KwanNorthwestern University Feinberg School of Medicine, Chicago, IL, USA.
Sneha PoondruDepartment of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, USA.
Corinne H MillerNorthwestern University Feinberg School of Medicine, Chicago, IL, USA.
Roopal V KunduNorthwestern University Feinberg School of Medicine, Chicago, IL, USA. roopal.kundu@nm.org.
Northwestern University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKeloids are pathologic scars that pose a significant functional and cosmetic burden. They are challenging to treat, despite the multitude of treatment modalities currently available.

objectiveThe aim of this study was to conduct an evidence-based review of all prospective data regarding keloid treatments published between 2010 and 2020.

methodsA systematic literature search of PubMed (National Library of Medicine), Embase (Elsevier), and Cochrane Library (Wiley) was performed in November of 2020. Search strategies with the keywords "keloid" and "treatment" were performed by a medical librarian. The search was limited to prospective studies that were peer-reviewed, reported on clinical outcomes of keloid therapies, and were published in the English language between January 1, 2010, and November 24, 2020.

resultsA total of 3462 unique citations were identified, of which 108 studies met inclusion criteria. Current literature supports silicone gel or sheeting with corticosteroid injections as first-line therapy for keloids. Adjuvant intralesional 5-fluorouracil (5-FU), bleomycin, or verapamil can be considered, although mixed results have been reported with each. Laser therapy can be used in combination with intralesional corticosteroids or topical steroids with occlusion to improve drug penetration. Excision of keloids with immediate post-excision radiation therapy is an effective option for recalcitrant lesions. Finally, silicone sheeting and pressure therapy have evidence for reducing keloid recurrence.

conclusionsThis review was limited by heterogeneity of subject characteristics and study outcome measures, small sample sizes, and inconsistent study designs. Larger and more robust controlled studies are necessary to further understand the variety of existing and emerging keloid treatments, including corticosteroids, cryotherapy, intralesional injections, lasers, photodynamic therapy, excision and radiation, pressure dressings, and others.

Indexed as

KeloidAdrenal Cortex HormonesFluorouracilHumansProspective StudiesTreatment OutcomeVerapamilAdrenal Cortex HormonesFluorouracilVerapamil

Identifiers

PMID36918908
PMCPMC10012475
OpenAlexW4324311402

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read394
reference markers read4
identifiers read1
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.